News and stories about members of the UNC Lineberger Cancer Cell Biology Research Program
The UNC RNA Discovery Center has awarded three fellowship grants to support innovative research investigating various roles of RNA in health and disease.
A team of UNC researchers have discovered how colon cancer “hijacks” enzyme motif mutations, a finding that may help identify new targets or directions for cancer treatments.
The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.
H. Shelton “Shelley” Earp, MD, director of the UNC Lineberger Comprehensive Cancer Center and UNC Cancer Care, received the prestigious Oliver Max Gardner Award.
Amy Gladfelter, PhD, was elected to the American Academy of Arts & Sciences. She is the eighth current UNC Lineberger member to earn this honor.
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
Albert Baldwin, PhD, is the 2022 recipient of the Hyman L. Battle Distinguished Cancer Research Award. The award recognizes exceptional cancer research at UNC-Chapel Hill.
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
The NCI awarded $9.3 million in support of two five-year research projects from researchers in the UNC Lineberger Pancreatic Cancer Center of Excellence in partnership with other institutions.
View all program news